---
document_datetime: 2024-12-12 11:09:51
document_pages: 10
document_pathfilename: www.ema.europa.eu/en/documents/procedural-steps-after/cystadane-epar-procedural-steps-taken-scientific-information-after-authorisation_en.pdf
document_name: cystadane-epar-procedural-steps-taken-scientific-information-after-authorisation_en.pdf
version: success
processing_time: 6.8170125
conversion_datetime: 2025-12-28 12:17:39.320843
docling_version:
  docling-serve: 1.9.0
  docling-jobkit: 1.8.0
  docling: 2.66.0
  docling-core: 2.57.0
  docling-ibm-models: 3.10.3
  docling-parse: 4.7.2
  python: cpython-313 (3.13.11)
  plaform: macOS-26.2-arm64-arm-64bit-Mach-O
---
## Cystadane

Procedural steps taken and scientific information after the authorisation

| Application number   | Scope                                                                                                                                                                                                                                                 | Opinion/ Notification 1 issued on   | Commission Decision Issued 2 / amended on   | Product Information affected 3   | Summary   |
|----------------------|-------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|-------------------------------------|---------------------------------------------|----------------------------------|-----------|
| IAIN/0042/G          | This was an application for a group of variations. B.II.b.2.c.1 - Change to importer, batch release arrangements and quality control testing of the FP - Replacement or addition of a manufacturer responsible for importation and/or batch release - | 10/12/2024                          |                                             | SmPC, Annex II, Labelling and PL |           |

<!-- image -->

<!-- image -->

<div style=\"page-break-after: always\"></div>

|                   | Not including batch control/testing A.1 - Administrative change - Change in the name and/or address of the MAH                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                   |            |     |                                   |
|-------------------|------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|------------|-----|-----------------------------------|
| IA/0041           | B.I.a.3.a - Change in batch size (including batch size ranges) of AS or intermediate - Up to 10-fold increase compared to the originally approved batch size                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                     | 22/04/2024 | n/a |                                   |
| IA/0040/G         | This was an application for a group of variations. B.I.b.1.c - Change in the specification parameters and/or limits of an AS, starting material/intermediate/reagent - Addition of a new specification parameter to the specification with its corresponding test method B.I.b.1.d - Change in the specification parameters and/or limits of an AS, starting material/intermediate/reagent - Deletion of a non- significant specification parameter (e.g. deletion of an obsolete parameter) B.I.b.1.d - Change in the specification parameters and/or limits of an AS, starting material/intermediate/reagent - Deletion of a non- significant specification parameter (e.g. deletion of an obsolete parameter) | 31/10/2023 | n/a |                                   |
| PSUSA/390/2 02302 | Periodic Safety Update EU Single assessment - betaine anhydrous (centrally authorised product only)                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                              | 26/10/2023 | n/a | PRAC Recommendation - maintenance |

<div style=\"page-break-after: always\"></div>

| IB/0038           | C.I.11.z - Introduction of, or change(s) to, the obligations and conditions of a marketing authorisation, including the RMP - Other variation                                                                                                                                                                                                                                                                                                                                                                                                                                        | 19/07/2021   | n/a        |                                  |                                   |
|-------------------|--------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|--------------|------------|----------------------------------|-----------------------------------|
| IAIN/0037         | B.IV.1.a.1 - Change of a measuring or administration device - Addition or replacement of a device which is not an integrated part of the primary packaging - Device with CE marking                                                                                                                                                                                                                                                                                                                                                                                                  | 30/04/2021   | n/a        |                                  |                                   |
| IA/0036           | B.II.e.1.a.1 - Change in immediate packaging of the finished product - Qualitative and quantitative composition - Solid pharmaceutical forms                                                                                                                                                                                                                                                                                                                                                                                                                                         | 29/01/2021   | n/a        |                                  |                                   |
| PSUSA/390/2 02002 | Periodic Safety Update EU Single assessment - betaine anhydrous (centrally authorised product only)                                                                                                                                                                                                                                                                                                                                                                                                                                                                                  | 01/10/2020   | n/a        |                                  | PRAC Recommendation - maintenance |
| IG/1085/G         | This was an application for a group of variations. A.1 - Administrative change - Change in the name and/or address of the MAH A.5.a - Administrative change - Change in the name and/or address of a manufacturer/importer responsible for batch release A.5.a - Administrative change - Change in the name and/or address of a manufacturer/importer responsible for batch release A.5.b - Administrative change - Change in the name and/or address of a manufacturer/importer of the finished product, including quality control sites (excluding manufacturer for batch release) | 16/05/2019   | 23/04/2020 | SmPC, Annex II, Labelling and PL |                                   |

<div style=\"page-break-after: always\"></div>

| N/0033            | Minor change in labelling or package leaflet not connected with the SPC (Art. 61.3 Notification)                                                                                                                                                                                                                                                                                                                                                                                                         | 05/03/2019   | 23/04/2020   | PL               |                                   |
|-------------------|----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|--------------|--------------|------------------|-----------------------------------|
| IAIN/0032         | B.II.b.1.a - Replacement or addition of a manufacturing site for the FP - Secondary packaging site                                                                                                                                                                                                                                                                                                                                                                                                       | 11/10/2018   | n/a          |                  |                                   |
| N/0031            | Minor change in labelling or package leaflet not connected with the SPC (Art. 61.3 Notification)                                                                                                                                                                                                                                                                                                                                                                                                         | 24/07/2018   | 23/04/2020   | Labelling and PL |                                   |
| IB/0030/G         | This was an application for a group of variations. B.I.a.1.z - Change in the manufacturer of AS or of a starting material/reagent/intermediate for AS - Other variation B.I.a.4.b - Change to in-process tests or limits applied during the manufacture of the AS - Addition of a new in-process test and limits B.I.b.2.a - Change in test procedure for AS or starting material/reagent/intermediate - Minor changes to an approved test procedure B.I.c.1.a - Change in immediate packaging of the AS | 25/10/2017   | n/a          |                  |                                   |
| PSUSA/390/2 01702 | Periodic Safety Update EU Single assessment - betaine anhydrous (centrally authorised product only)                                                                                                                                                                                                                                                                                                                                                                                                      | 28/09/2017   | n/a          |                  | PRAC Recommendation - maintenance |
| II/0029           | B.I.b.1.f - Change in the specification parameters and/or limits of an AS, starting material/intermediate/reagent - Change outside the approved specifications limits range for the AS                                                                                                                                                                                                                                                                                                                   | 14/09/2017   | n/a          |                  |                                   |

<div style=\"page-break-after: always\"></div>

| IG/0773/G         | This was an application for a group of variations. B.II.b.1.a - Replacement or addition of a manufacturing site for the FP - Secondary packaging site B.II.b.2.c.1 - Change to importer, batch release arrangements and quality control testing of the FP - Replacement or addition of a manufacturer responsible for importation and/or batch release - Not including batch control/testing   | 14/02/2017   |            | Annex II and PL                  |                                                                                                                                                                                                                                                                         |
|-------------------|------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|--------------|------------|----------------------------------|-------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|
| IA/0026           | B.II.d.2.a - Change in test procedure for the finished product - Minor changes to an approved test procedure                                                                                                                                                                                                                                                                                   | 12/01/2017   | n/a        |                                  |                                                                                                                                                                                                                                                                         |
| PSUSA/390/2 01602 | Periodic Safety Update EU Single assessment - betaine anhydrous (centrally authorised product only)                                                                                                                                                                                                                                                                                            | 13/10/2016   | 08/12/2016 | SmPC, Annex II, Labelling and PL | Refer to Scientific conclusions and grounds recommending the variation to terms of the Marketing Authorisation(s)' for PSUSA/390/201602.                                                                                                                                |
| R/0024            | Renewal of the marketing authorisation.                                                                                                                                                                                                                                                                                                                                                        | 15/09/2016   | 21/11/2016 | SmPC, Annex II, Labelling and PL | Based on the review of data on quality, safety and efficacy, the CHMP considered that the benefit-risk balance of Cystadane in the approved indication remains favourable and therefore recommended the renewal of the marketing authorisation with unlimited validity. |
| II/0025           | Submission of the final report of Cystadane Surveillance Protocol (in collaboration with E-HOD) registry: to obtain long-term clinical and safety information in patients with cystathionine betasynthase (CBS), 5, 10-                                                                                                                                                                        | 15/09/2016   | n/a        |                                  |                                                                                                                                                                                                                                                                         |

<div style=\"page-break-after: always\"></div>

|                   | cobalamin cofactor metabolism (Cbl) and treated with Cystadane. C.I.13 - Other variations not specifically covered elsewhere in this Annex which involve the submission of studies to the competent authority   |            |            |             |                                                                                                                                          |
|-------------------|-----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|------------|------------|-------------|------------------------------------------------------------------------------------------------------------------------------------------|
| IG/0686           | B.II.b.1.a - Replacement or addition of a manufacturing site for the FP - Secondary packaging site                                                                                                              | 12/05/2016 | n/a        |             |                                                                                                                                          |
| PSUSA/390/2 01502 | Periodic Safety Update EU Single assessment - betaine anhydrous (centrally authorised product only)                                                                                                             | 24/09/2015 | 19/11/2015 | SmPC and PL | Refer to Scientific conclusions and grounds recommending the variation to terms of the Marketing Authorisation(s)' for PSUSA/390/201502. |
| IA/0021           | A.8 - Administrative change - Changes to date of the audit to verify GMP compliance of the manufacturer of AS                                                                                                   | 30/07/2015 | n/a        |             |                                                                                                                                          |
| IG/0535           | C.I.8.a - Introduction of or changes to a summary of Pharmacovigilance system - Changes in QPPV (including contact details) and/or changes in the PSMF location                                                 | 06/03/2015 | n/a        |             |                                                                                                                                          |
| IB/0018           | B.II.d.1.d - Change in the specification parameters and/or limits of the finished product - Deletion of a non-significant specification parameter                                                               | 22/12/2014 | n/a        |             |                                                                                                                                          |
| IB/0017           | B.II.d.2.d - Change in test procedure for the finished product - Other changes to a test procedure (including replacement or addition)                                                                          | 07/11/2014 | n/a        |             |                                                                                                                                          |

<div style=\"page-break-after: always\"></div>

| IA/0016     | A.7 - Administrative change - Deletion of manufacturing sites                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                   | 23/10/2014   | n/a   |                                   |
|-------------|-------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|--------------|-------|-----------------------------------|
| PSUV/0015   | Periodic Safety Update                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                          | 11/09/2014   | n/a   | PRAC Recommendation - maintenance |
| IB/0014     | B.I.a.1.z - Change in the manufacturer of AS or of a starting material/reagent/intermediate for AS - Other variation                                                                                                                                                                                                                                                                                                                                                                                                                                                                            | 14/05/2014   | n/a   |                                   |
| IA/0013/G   | This was an application for a group of variations. A.5.b - Administrative change - Change in the name and/or address of a manufacturer/importer of the finished product, including quality control sites (excluding manufacturer for batch release) A.5.b - Administrative change - Change in the name and/or address of a manufacturer/importer of the finished product, including quality control sites (excluding manufacturer for batch release) B.II.e.7.b - Change in supplier of packaging components or devices (when mentioned in the dossier) - Replacement or addition of a supplier | 12/03/2014   | n/a   |                                   |
| IAIN/0012/G | This was an application for a group of variations. A.5.a - Administrative change - Change in the name and/or address of a manufacturer/importer responsible for batch release A.7 - Administrative change - Deletion of manufacturing sites B.I.a.2.a - Changes in the manufacturing process of the AS - Minor change in the manufacturing process                                                                                                                                                                                                                                              | 28/02/2014   | n/a   |                                   |

<div style=\"page-break-after: always\"></div>

|         | of the AS B.II.e.7.b - Change in supplier of packaging components or devices (when mentioned in the dossier) - Replacement or addition of a supplier                                                                                                                                                       |            |            |                                  |                                                                                                                                                                                                                                                                                                                                                                                                                                                  |
|---------|------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|------------|------------|----------------------------------|--------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|
| IG/0393 | C.I.8.a - Introduction of or changes to a summary of Pharmacovigilance system - Changes in QPPV (including contact details) and/or changes in the PSMF location                                                                                                                                            | 20/12/2013 | n/a        |                                  |                                                                                                                                                                                                                                                                                                                                                                                                                                                  |
| IG/0392 | B.II.b.2.c.1 - Change to importer, batch release arrangements and quality control testing of the FP - Replacement or addition of a manufacturer responsible for importation and/or batch release - Not including batch control/testing                                                                     | 19/12/2013 | 06/02/2014 | Annex II and PL                  |                                                                                                                                                                                                                                                                                                                                                                                                                                                  |
| II/0008 | The MAH proposed to delete the following condition from the Annex II: Submission of an updated RMP which includes description and timelines of the re- started ROCH registry and of the new E-IMD registry. C.I.z - Changes (Safety/Efficacy) of Human and Veterinary Medicinal Products - Other variation | 21/02/2013 | 06/02/2014 | Annex II                         | Following the assessment of an updated RMP which included: - Description and timelines of the re-started ROCH registry - Description and timelines of the new E-IMD registry the CHMP agreed that the above mentioned obligations have been fulfilled, and therefore recommends their deletion from the Annex II. Both study protocols were found acceptable and minor recommendations were made for an updated RMP and updated study protocols. |
| N/0009  | Minor change in labelling or package leaflet not connected with the SPC (Art. 61.3 Notification)                                                                                                                                                                                                           | 12/09/2012 | 06/02/2014 | Labelling and PL                 |                                                                                                                                                                                                                                                                                                                                                                                                                                                  |
| R/0006  | Renewal of the marketing authorisation.                                                                                                                                                                                                                                                                    | 15/12/2011 | 13/02/2012 | SmPC, Annex II, Labelling and PL | Based upon the data that have become available since the granting of the initial Marketing Authorisation, the CHMP considers that the benefit-risk balance of Cystadane                                                                                                                                                                                                                                                                          |

<div style=\"page-break-after: always\"></div>

|         |                                                                                                                                                                                                             |            |     |                        | remains positive, but considers that its safety profile is to be closely monitored for the following reasons: At licensing time the MAH committed to set up a registry (ROCH: Registry for Cystadane - Homocystinuria) to collect more data on safety and efficacy of Cystadane. However, from this registry only limited additional data was gathered. Therefore this registry was stopped to be replaced by another database (E-IMD: European Intoxication type Metabolic Disorders). As from neither this new registry nor the (restarted) old registry any additional data are available yet, the original commitment has been extended, in order to receive and analyse enough data from both registries for granting a renewal with unlimited validity. Therefore, based upon the safety profile of Cystadane, which requires the submission of 1- yearly PSURs, the CHMP concluded that the MAH should submit one additional   |
|---------|-------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|------------|-----|------------------------|---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|
| IG/0111 | C.I.9.i - Changes to an existing pharmacovigilance system as described in the DDPS - Change(s) to a DDPS following the assessment of the same DDPS in relation to another medicinal product of the same MAH | 27/09/2011 | n/a | Annex II               |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                       |
| N/0005  | Minor change in labelling or package leaflet not connected with the SPC (Art. 61.3 Notification)                                                                                                            | 04/03/2011 | n/a | PL                     |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                       |
| IB/0004 | IB_42_a_02_Change in shelf-life of finished product - after first opening                                                                                                                                   | 31/07/2008 | n/a | SmPC, Labelling and PL |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                       |
| IB/0003 | IB_42_a_01_Change in shelf-life of finished product - as packaged for sale                                                                                                                                  | 23/11/2007 | n/a | SmPC and PL            |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                       |

<div style=\"page-break-after: always\"></div>

| IA/0002   | IA_01_Change in the name and/or address of the marketing authorisation holder IA_05_Change in the name and/or address of a of the finished product   | 09/10/2007   | n/a   | SmPC, Annex II, Labelling and PL   | manufacturer   |
|-----------|------------------------------------------------------------------------------------------------------------------------------------------------------|--------------|-------|------------------------------------|----------------|
| IA/0001   | IA_08_a_Change in BR/QC testing - repl./add. of batch control/testing site                                                                           | 02/05/2007   | n/a   |                                    |                |